Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?
作者信息
Struthers A D
出版信息
Br Heart J. 1993 Nov;70(5):397-8. doi: 10.1136/hrt.70.5.397.
Abstract
摘要
相似文献
1
Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?脑钠肽的血浆浓度：这项新检测会减少心脏检查的需求吗？
Br Heart J. 1993 Nov;70(5):397-8. doi: 10.1136/hrt.70.5.397.
2
Cardiac natriuretic peptides as predictors of mortality.心脏利钠肽作为死亡率的预测指标。
J Intern Med. 1997 Apr;241(4):257-9. doi: 10.1046/j.1365-2796.1997.295134000.x.
3
Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.血浆心钠素测定作为检测轻度左心室功能损害患者的筛查试验。
Heart. 1996 Sep;76(3):232-7. doi: 10.1136/hrt.76.3.232.
4
[Human atrial natriuretic peptide (hANP), human brain natriuretic peptide (hBNP)].[人心房利钠肽（hANP），人脑利钠肽（hBNP）]
Nihon Rinsho. 1995 Mar;53 Su Pt 2:737-40.
5
N-terminal pro A-type natriuretic peptide but not N-terminal pro C-type natriuretic peptide concentrations are related to cardiac diseases in infants.
Clin Chim Acta. 2008 May;391(1-2):118-9. doi: 10.1016/j.cca.2008.01.022. Epub 2008 Jan 30.
6
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.充血性心力衰竭患者血浆中 A 型利钠肽和 B 型利钠肽浓度对血管紧张素转换酶抑制剂阿拉普利的反应。
Br Heart J. 1995 Jun;73(6):584-5. doi: 10.1136/hrt.73.6.584-b.
7
8
Brain and atrial natriuretic peptide plasma concentrations in normal healthy children.正常健康儿童的脑钠肽和心房利钠肽血浆浓度
Br J Biomed Sci. 1993 Jun;50(2):92-5.
9
Assessment of heart failure with plasma natriuretic peptides.利用血浆利钠肽评估心力衰竭
Lancet. 1998 Feb 7;351(9100):444; author reply 445. doi: 10.1016/s0140-6736(05)78387-2.
10
Assessment of heart failure with plasma natriuretic peptides.利用血浆利钠肽评估心力衰竭
Lancet. 1998 Feb 7;351(9100):444; author reply 445. doi: 10.1016/s0140-6736(05)78386-0.
引用本文的文献
1
Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only.引入脑钠肽（BNP）的一个新作用：作为心脏结构疾病的一般指标，而非仅作为收缩功能障碍的特定指标。
Heart. 2002 Feb;87(2):97-8. doi: 10.1136/heart.87.2.97.
2
Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.循证心脏病学：充血性心力衰竭的预防及无症状左心室功能障碍的管理
BMJ. 1999 May 22;318(7195):1400-2. doi: 10.1136/bmj.318.7195.1400.
3
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.通过高灵敏度和特异性免疫放射分析测定的正常受试者和不同程度心力衰竭患者的循环中心脏利钠肽（心房钠尿肽和脑钠肽）水平。
J Endocrinol Invest. 1998 Mar;21(3):170-9. doi: 10.1007/BF03347297.
4
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice.脑钠肽在全血中稳定，可通过简单快速检测法进行测定：对临床实践的意义。
Heart. 1997 Dec;78(6):594-7. doi: 10.1136/hrt.78.6.594.
5
Neuroendocrine changes in chronic cardiac failure.慢性心力衰竭中的神经内分泌变化
Basic Res Cardiol. 1996;91 Suppl 1:13-20. doi: 10.1007/BF00810519.
6
Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?十年利钠肽研究：其诊断与治疗应用的新曙光？
BMJ. 1994 Jun 18;308(6944):1615-9. doi: 10.1136/bmj.308.6944.1615.
7
Management of patients after their first myocardial infarction.首次心肌梗死后患者的管理。
BMJ. 1994 Oct 29;309(6962):1129-34. doi: 10.1136/bmj.309.6962.1129.
8
Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.症状性左心室功能不全诊断中的测力计运动测试和环磷酸鸟苷（cGMP）敏感性
Br Heart J. 1995 Feb;73(2):145-50. doi: 10.1136/hrt.73.2.145.
9
Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.心肌梗死后血浆心钠素原（1-98）浓度：与心脏和肾功能指标的关系。
Br Heart J. 1995 Jun;73(6):511-6. doi: 10.1136/hrt.73.6.511.
本文引用的文献
1
Screening for hypertrophic cardiomyopathy.肥厚型心肌病的筛查
BMJ. 1993 Feb 13;306(6875):409-10. doi: 10.1136/bmj.306.6875.409.
2
Echocardiography in chronic heart failure in the community.社区慢性心力衰竭的超声心动图检查
Q J Med. 1993 Jan;86(1):17-23.
3
Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.脑钠素：心脏病患者局部血浆浓度及其与血流动力学状态的相关性
Br Heart J. 1993 May;69(5):414-7. doi: 10.1136/hrt.69.5.414.
4
Increased plasma levels of brain natriuretic peptide in hypertrophic cardiomyopathy.
N Engl J Med. 1993 Aug 5;329(6):433-4. doi: 10.1056/nejm199308053290614.
5
Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.血浆脑钠肽作为心肌梗死后血管紧张素转换酶抑制的指标。
Lancet. 1993 May 1;341(8853):1109-13. doi: 10.1016/0140-6736(93)93126-l.
6
Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.循环N端心房利钠肽作为无症状左心室功能障碍的标志物。
Lancet. 1993 May 1;341(8853):1105-9. doi: 10.1016/0140-6736(93)93125-k.
7
Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain.脑钠肽-32：在猪脑中鉴定出的脑钠肽的N端六氨基酸延伸形式。
Biochem Biophys Res Commun. 1988 Sep 15;155(2):726-32. doi: 10.1016/s0006-291x(88)80555-2.
8
The differential response in atrial natriuretic peptide release during exercise in patients with and without ischemic heart disease.
Am J Med Sci. 1988 Aug;296(2):111-3. doi: 10.1097/00000441-198808000-00007.
9
A new natriuretic peptide in porcine brain.猪脑中一种新的利钠肽。
Nature. 1988 Mar 3;332(6159):78-81. doi: 10.1038/332078a0.
10
Correlates of plasma atrial natriuretic factor in health and hypertension.健康与高血压状态下血浆心钠素的相关因素
Hypertension. 1987 Dec;10(6):570-6. doi: 10.1161/01.hyp.10.6.570.
Zotero 插件